Filing Flows › Xtant Medical Holdings (XTNT) › Stock forecast & fair value
Xtant Medical Holdings (XTNT) stock forecast and price target
Xtant Medical Holdings (XTNT) trades at $0.29. 3 analysts' median price target is $1.00 (+246%), from $0.60 to $1.50.
Xtant Medical Holdings' latest quarter
Xtant Medical Holdings, Q2 2026: revenue $23.0M (-35% year over year), operating margin -39.8%, net loss $9.4M, operating cash flow −$7.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for XTNT stock?
The median of 3 analysts' 12-month targets is $1.00, +246% from $0.29; the range is $0.60 to $1.50. The average rating is none.
Does Xtant Medical Holdings usually beat earnings estimates?
It beat the consensus EPS estimate in 50% of the quarters on record.
Is XTNT stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.